Bexen Cardio obtains MDR certification for its Reanibex 300 and 500 defibrillators
Bexen Cardio’s Reanibex 300 and 500 defibrillators have received CE certification under Regulation (EU) 2017/745 on medical devices (MDR). This certification ensures the highest level of safety and performance of our equipment. Additionally, these defibrillators are classified as Class III Medical Devices, the highest risk category under the regulation.
The certification confirms that Bexen Cardio complies with the most stringent safety standards and that our products are high-quality, effective, and reliable for both patients and users. It is also worth remembering that our Quality Management System has been certified under the MDR for three years now, further reinforcing our commitment to excellence and European regulatory compliance.
The MDR aims to ensure a high level of safety and quality for medical devices manufactured or supplied within the European territory.
Over the past years, we at Bexen Cardio have made a great effort to adapt to MDR requirements. It has been a long and complex process, during which we have had to overcome various challenges: the bottleneck caused by Notified Bodies and extremely long waiting times, the adaptation of our quality management system, and the technical documentation of our products. This major milestone, of which we are very proud, has been made possible thanks to the involvement and effort of all our staff.
At Bexen Cardio, we continue working to obtain MDR certification for the rest of our products and, in the near future, we hope to announce new certifications that reinforce our commitment to safety, quality, and regulatory excellence.